Frazier Financial Advisors LLC Purchases New Position in Zomedica Corp. (NYSEAMERICAN:ZOM)

Frazier Financial Advisors LLC acquired a new stake in Zomedica Corp. (NYSEAMERICAN:ZOM) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 250,000 shares of the company’s stock, valued at approximately $50,000.

Separately, Sequoia Financial Advisors LLC purchased a new position in Zomedica in the 4th quarter worth approximately $43,000. 8.95% of the stock is owned by institutional investors and hedge funds.

Zomedica Stock Performance

Shares of Zomedica stock traded down $0.00 during trading on Thursday, reaching $0.18. The company’s stock had a trading volume of 3,225,188 shares, compared to its average volume of 5,877,556. The stock has a market capitalization of $176.49 million, a price-to-earnings ratio of -4.55 and a beta of 0.99. Zomedica Corp. has a 52-week low of $0.12 and a 52-week high of $0.25.

Zomedica (NYSEAMERICAN:ZOM) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.01) earnings per share for the quarter. Zomedica had a negative net margin of 143.67% and a negative return on equity of 8.62%. The company had revenue of $6.26 million during the quarter.

Zomedica Company Profile

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.